Antibiotic prevention with Levofloxacin in children with Acute Lymphoblastic Leukemia
Phase 3
Recruiting
- Conditions
- Acute lymphoblastic leukemiaC04.557.337.428.600
- Registration Number
- RBR-9z76pk4
- Lead Sponsor
- Hospital de Clínicas de Porto Alegre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with an initial diagnosis of Acute Lymphoblastic Leukemia; age from 1 year to 18 years.
Exclusion Criteria
Children with clinically or microbiologically documented infection before initiation of induction or with fever before induction therapy that required prolonged antibiotic therapy (more than 5 days); history of allergy to the use of quinolones; history of chronic arthritis being treated; patients who developed febrile neutropenia within the first 7 days of induction.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method